Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Pharmacology
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Molecular Pharmacology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Visit molpharm on Facebook
  • Follow molpharm on Twitter
  • Follow molpharm on LinkedIn
Research ArticleArticle

Homologous Regulation of Mu Opioid Receptor Recycling by Gβγ, Protein Kinase C, and Receptor Phosphorylation

Jennifer M. Kunselman, Amanda S. Zajac, Zara Y. Weinberg and Manojkumar A. Puthenveedu
Molecular Pharmacology December 2019, 96 (6) 702-710; DOI: https://doi.org/10.1124/mol.119.117267
Jennifer M. Kunselman
Cellular and Molecular Biology Program (J.M.K., M.A.P.) and Department of Pharmacology (J.M.K., Z.Y.W., M.A.P.), University of Michigan, Ann Arbor, Michigan; and Department of Biological Sciences, Carnegie Mellon University, Pittsburgh, Pennsylvania (A.S.Z., M.A.P.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Jennifer M. Kunselman
Amanda S. Zajac
Cellular and Molecular Biology Program (J.M.K., M.A.P.) and Department of Pharmacology (J.M.K., Z.Y.W., M.A.P.), University of Michigan, Ann Arbor, Michigan; and Department of Biological Sciences, Carnegie Mellon University, Pittsburgh, Pennsylvania (A.S.Z., M.A.P.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Zara Y. Weinberg
Cellular and Molecular Biology Program (J.M.K., M.A.P.) and Department of Pharmacology (J.M.K., Z.Y.W., M.A.P.), University of Michigan, Ann Arbor, Michigan; and Department of Biological Sciences, Carnegie Mellon University, Pittsburgh, Pennsylvania (A.S.Z., M.A.P.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Zara Y. Weinberg
Manojkumar A. Puthenveedu
Cellular and Molecular Biology Program (J.M.K., M.A.P.) and Department of Pharmacology (J.M.K., Z.Y.W., M.A.P.), University of Michigan, Ann Arbor, Michigan; and Department of Biological Sciences, Carnegie Mellon University, Pittsburgh, Pennsylvania (A.S.Z., M.A.P.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Manojkumar A. Puthenveedu
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF + SI
  • PDF
Loading

Article Figures & Data

Figures

  • Additional Files
  • Fig. 1.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Fig. 1.

    The opioid agonist DAMGO increases postendocytic recycling of MOR. (A) HEK293 cell expressing SpH-MOR imaged with total internal reflection fluorescence microscopy after DAMGO addition. The appearance of an individual exocytic recycling event is denoted by red boxes. Images are 100 ms apart. Scale bar, 5 µm. (B) Profile of an individual exocytic event (puff) over 1 s. Frames are 100 ms apart. Scale bar, 1 μm. The event begins as a defined spot of fluorescence intensity that appears suddenly. The fluorescence diffuses on the cell membrane as shown by the heat map surface plot. (C) Experimental paradigm to study MOR postendocytic recycling. (D) The number of recycling events normalized to cell area (square micrometer) over time ± DAMGO washout after the baseline recording. In the −washout condition, P > 0.999 for baseline versus +1 minute and P = 0.306 for baseline versus +6 minutes (n = 15 cells). In the +washout condition, ****P < 0.0001 for both baseline versus 1-minute washout and baseline versus 6-minute washout (n = 27 cells). Mean and S.E.M. are plotted for each time point. (E) The percentage of recycling events in each condition (±washout) was normalized to the baseline events for each condition. ****P < 0.0001 for −washout 1 minute versus +washout 1 minute. ****P < 0.0001 for −washout 6 minutes versus +washout 6 minutes (−washout: n = 15 cells; +washout: n = 27 cells.) Box and whisker plots are shown with all points from each condition.

  • Fig. 2.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Fig. 2.

    The agonist-mediated increase in MOR recycling requires G protein signaling. (A) Representative images of HEK293 cell expressing SpH-MOR imaged with total internal reflection fluorescence microscopy before and after DAMGO addition. Cells pretreated with PTX 14–16 hours before imaging. Scale bar, 5 µm. (B) Following DAMGO addition, SpH-MOR clusters on the cell surface before internalizing in both control (Ctrl) and PTX-treated cells. Scale bar, 2.5 µm. (C) Quantification of percentage of normalized fluorescence in control and PTX conditions for the first 5 minutes following DAMGO addition. Values are normalized to the first frames following DAMGO addition (Ctrl: n = 10 cells; PTX: n = 8 cells). (D) Number of recycling events per cell area (square micrometer) over time in response to DAMGO washout ± PTX. P = 0.0064 for control baseline versus PTX baseline (Ctrl: n = 10 cells; PTX: n = 8 cells). Mean and S.E.M. are plotted for each time point. (E) Percentage of baseline recycling events/min at washout 6 minutes for each condition; ***P = 0.0003 for control washout 6 minutes versus PTX washout 6 minutes (Ctrl: n = 10 cells; PTX: n = 8 cells). Box and whisker plots are shown with all points from each condition. (F) Percentage of baseline recycling events/min in response to KT5720 (KT; n = 14 cells), forskolin (Fsk; n = 14 cells), or Fsk + KT (n = 14 cells); treatment normalized to initial baseline recycling events (one-sample t test: P = 0.908 for baseline vs. +KT; P = 0.9758 for baseline vs. +Fsk; P = 0.7886 for baseline vs. +Fsk+KT). Box and whisker plots are shown with all points from each condition. ns, not significant.

  • Fig. 3.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Fig. 3.

    Gβγ activation is required and sufficient to increase MOR recycling. (A) Number of MOR recycling events per cell area (square micrometer) over time in response to a DAMGO washout in control (Ctrl) and gallein conditions. Cells were treated with gallein 30 minutes prior to imaging. P = 0.0046 for control baseline versus gallein baseline (Ctrl: n = 9 cells; gallein: n = 25 cells). Mean and S.E.M. are plotted for each time point. (B) Percentage of baseline recycling events/min at washout 6 minutes for each condition: P = 0.0015 for control washout 6 minutes versus gallein washout 6 minutes (Ctrl: n = 9 cells; gallein: n = 25 cells). Box and whisker plots are shown with all points from each condition. (C) Number of MOR recycling events per cell area (square micrometer) over time in response to a DAMGO washout in control, mSIRK, and 12155 conditions. Cells were treated acutely with mSIRK or 12155 during the washout. Mean and S.E.M. are plotted for each time point (Ctrl: n = 10 cells; mSIRK: n = 12 cells; 12155: n = 12 cells). (D) Percentage of baseline recycling events/min at washout 1 minute for each condition: ***P = 0.0003 for control washout 1 minute versus mSIRK washout 1 minute; *P = 0.0488 for control washout 1 minute versus 12155 washout 1 minute (Ctrl: n = 10 cells; mSIRK: n = 12 cells; 12155: n = 12 cells). Box and whisker plots are shown with all points from each condition. (E) Changes in surface MOR fluorescence over time measured after DAMGO addition and washout. MOR fluorescence decreased upon receptor internalization after DAMGO addition and returned upon recycling after DAMGO washout. Gβγ activation by either mSIRK or 12155 increased the rate of recovery of fluorescence. Scale bar, 10 μm. (F) Quantification of fluorescence recovery over 30 minutes following DAMGO treatment normalized to the baseline fluorescence. (G) Quantification of fluorescence recovery normalized to the fluorescence loss before washout for control, mSIRK, or 12155 conditions. (H) Box and whisker plots showing the fluorescence after 15 minutes of agonist washout in control, mSIRK, or 12155 conditions. Gβγ activation by either mSIRK or 12155 increased the receptors recycled; ****P < 0.0001 for control versus mSIRK, **P = 0.0058 for control versus 12155 (Ctrl: n = 48 fields; mSIRK: n = 44 fields; 12155: n = 38 fields, all across three independent experiments).

  • Fig. 4.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Fig. 4.

    Homologous regulation of MOR recycling by MOR phosphorylation at serine 363. (A) Percentage of baseline recycling events/min in response to U73122 (n = 17 cells) or U73343 (n = 21 cells) treatment normalized to initial baseline recycling events. One-sample t test: ***P = 0.0002 for baseline versus U73122; P = 0.8910 for baseline versus U73343. Box and whisker plots are shown with all points from each condition. (B) Percentage of baseline recycling events/min in response to chelerythrine (n = 20 cells) or Gö6983 (n = 21 cells) treatment normalized to initial baseline recycling events. One-sample t test: ***P = 0.0007 for baseline versus chelerythrine; ****P < 0.0001 for baseline versus Gö6983. Box and whisker plots are shown with all points from each condition. (C) Number of recycling events per cell area (square micrometer) over time in response to DAMGO washout in control (Ctrl), S363A, S363A + gallein, or S363D conditions. P = 0.0392 for control baseline vs. S363A baseline; P = 0.0429 for control baseline vs. S363A + gallein baseline; P = 0.7203 for control baseline vs. S363D baseline; P = 0.9391 for S363D baseline vs. S363D washout 6 minutes (Ctrl: n = 18 cells; S363A: n = 15 cells; S363A + gallein: n = 19 cells; S363D: n = 10 cells). Mean and S.E.M. are plotted for each time point. (D) Percentage of baseline recycling events/min at washout 6 minute for each condition: ***P = 0.0003 for control washout 6 minute versus S363A washout 6 minutes; **P = 0.0077 for control washout 6 minutes versus S363A + gallein washout 6 minutes; ****P < 0.0001 for control washout 6 minutes versus S363D washout 6 minutes (Ctrl: n = 18 cells; S363A: n = 15 cells; S363A + gallein: n = 19 cells; S363D: n = 10 cells). Box and whisker plots are shown with all points from each condition. (E) Proposed model of self-regulation of postendocytic recycling of MOR. ns, not significant.

Additional Files

  • Figures
  • Data Supplement

    • Supplemental Data -

      Supplementary Figure 1 - Clustering and Internalization of MOR across conditions.

      Supplementary Figure 2 - Raw MOR recycling events across all conditions.

    • Supplemental Movie -

      Supplementary Movie 1 - An example movie of exocytic events in a cell following agonist treatment.

PreviousNext
Back to top

In this issue

Molecular Pharmacology: 96 (6)
Molecular Pharmacology
Vol. 96, Issue 6
1 Dec 2019
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Editorial Board (PDF)
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Molecular Pharmacology article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Homologous Regulation of Mu Opioid Receptor Recycling by Gβγ, Protein Kinase C, and Receptor Phosphorylation
(Your Name) has forwarded a page to you from Molecular Pharmacology
(Your Name) thought you would be interested in this article in Molecular Pharmacology.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleArticle

G Proteins Regulate Mu Opioid Receptor Recycling

Jennifer M. Kunselman, Amanda S. Zajac, Zara Y. Weinberg and Manojkumar A. Puthenveedu
Molecular Pharmacology December 1, 2019, 96 (6) 702-710; DOI: https://doi.org/10.1124/mol.119.117267

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Research ArticleArticle

G Proteins Regulate Mu Opioid Receptor Recycling

Jennifer M. Kunselman, Amanda S. Zajac, Zara Y. Weinberg and Manojkumar A. Puthenveedu
Molecular Pharmacology December 1, 2019, 96 (6) 702-710; DOI: https://doi.org/10.1124/mol.119.117267
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Introduction
    • Materials and Methods
    • Results
    • Discussion
    • Acknowledgments
    • Authorship Contributions
    • Footnotes
    • Abbreviations
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF + SI
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • 6-Methylflavone Blocks Bitterness of Tenofovir
  • Positive Allosteric Modulation of the mGlu5 Receptor
  • Correction of mutant CNGA3 channel trafficking defect
Show more Articles

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Molecular Pharmacology
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0111 (Online)

Copyright © 2021 by the American Society for Pharmacology and Experimental Therapeutics